Search
for
Sort by
Research 391–420 of 1000+
- Teriflunomide: A Once-daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis
- Chemoprevention of smoke-induced alopecia in mice by oral administration of l-cystine and vitamin B6
- Vesicular Carriers for Improved Oral Anticoagulation Competence of Rivaroxaban: In Vitro and In Vivo Investigation
- Efficacy of oral spironolactone in the treatment of androgenetic alopecia in female patients: A case series of 11 patients
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology
- Successful induction of oral tolerance in Netherton syndrome
- Efficacy of Oral Vitamin D<sub>3</sub> Therapy in Patients Suffering from Diffuse Hair Loss (Telogen Effluvium)
- The Effects of an Oral Supplementation of a Natural Keratin Hydrolysate on Skin Aging: A Randomized, Double‐Blind, Placebo‐Controlled Clinical Study in Healthy Women
- [Clinical findings with a low-dosed antiandrogene (cyproteronacetate) and aethinyloestradiol women with virilising symptoms (author's transl)].
- 41701 Efficacy of the Oral JAK1/JAK2 Inhibitor CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata: Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 Phase 3 Trial
- Effectiveness of oral tofacitinib treatment on patients with moderate‐to‐severe alopecia areata in Iran
- Clinical Role of Oral Vitamin C and E Therapy in Skin and Hair Disorders
- Commentary on article on clinical efficacy of oral finasteride by Won, Lew, and Sim
- Nonalimental Scurvy With Relapse Symptoms After Stopping Oral Vitamin C Supplementation
- Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Evaluation of acute, subacute oral toxicity and wound healing activity of mother plant and callus of Teucrium polium L. subsp. geyrii Maire from Algeria
- Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicenter, randomized, double-blinded, placebo-controlled trial
- Evaluation of ovarian reserve and function in female patients treated with oral isotretinoin for severe acne: an exploratory study
- The Role of Vitamin D3 Deficiency and Colonization of the Oral Mucosa by Candida Yeast-like Fungi in the Pathomechanism of Psoriasis
- Clinico-Epidemiological Aspects of Cutaneous Lesions in Injecting Drug Users Visiting an Oral Substitution Therapy Centre: A Cross-Sectional Study
- PWE-049 Assessment of response and tolerance to oral iron supplements in patients with anaemia
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- TREATMENT OF SEVERE ALOPECIA AREATA USING METHOTREXATE AS AN ADJUNCTIVE DRUG IN COMBINATION WITH INTRAVENOUS AND ORAL CORTICOSTEROID
- 265 Modulation of disease-central cytokine pathways with TAK-279, a highly selective oral tyrosine kinase 2 (TYK2) inhibitor, defines clinical response in patients with psoriasis
- Is the effect worth the risk? - The most common complaints during oral isotretinoin anti-acne therapy and controversies around its adverse effects
- Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study
- Zinc as an ambivalent but potent modulator of murine hair growth in vivo- preliminary observations